Olesja Bondarenko is senior researcher and team leader at the National Institute of Chemical Physics and Biophysics (Estonia) and a Marie Curie Individual Fellowship-funded postdoctoral researcher at the University of Helsinki (Finland). She co-authored over 30 peer-reviewed publications on the antibacterial and immune effects of nanoparticles, including several highly cited publications. Dr. Bondarenko is also a co-founder of the biotechnological company Nanordica Medical, which focuses on developing advanced antibacterial nanotechnology.